Table 3. Number of patients with AEs 1 week and/or 3 months after the first SIRT procedure.
| AE | Number with indicated AE (N=186), n (%) |
|---|---|
| Any | 75 (40.3)† |
| Gastrointestinal | |
| Abdominal pain | 28 (15.1) |
| Ascites | 21 (11.3) |
| Nausea | 12 (6.5) |
| Vomiting | 9 (4.8) |
| Decreased appetite | 8 (4.3) |
| Ulcer | 6 (12.4) |
| Bleeding | 10 (5.4) |
| General disorders | |
| Edema | 9 (4.8) |
| Fatigue | 12 (6.5) |
| Fever | 8 (4.3) |
| Nervous system | |
| Encephalopathy | 5 (2.7) |
| Local | |
| Groin pain | 4 (2.2) |
| Liver | |
| Jaundice | 4 (2.2) |
| Other | 20 (10.8)‡ |
†, percentages are relative to the number with data available; some patients had >1 AE. ‡, includes abdominal distention, acute kidney injury, blisters from chemotherapy, constipation (severe), dizziness, diarrhea, duodenal stricture, gastritis, hyponatremia, myalgia, metabolic acidosis, pain/pain at site, pleural effusion, seeing colors, seizures (in a patient with prior history), shortness of breath, stomach cramps, swelling/leg swelling, weight loss. AE, adverse event; SIRT, selective internal radiation therapy.